• Image of LYTGOBI medication Image of LYTGOBI medication
    • LYTGOBI

    • QTY 21
    • 12 MG/DAY
    • Tablet
    • Near  49120

FUTIBATINIB (FUE ti BA ti nib) treats bile duct cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.


LYTGOBI Lifestyle Interactions

  • Futibatinib 4mg, Oral tablet

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.
    Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during futibatinib treatment due to the risk of increased futibatinib exposure and adverse reactions. Futibatinib is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.